combination drug
Scope
Date
~
-
Mergers & Acquisitions
Materials, parts makers drive Korea's 2021 M&A boom
Materials, components and equipment makers drove South Korea's mergers and acquisitions market to a record high last year, with smaller deals involv...
Jan 18, 2022 (Gmt+09:00)
language -
ETFs
Mirae Asset’s global ETFs top 100 trillion won mark
Mirae Asset Global Investments Co.’s global equity-traded funds (ETFs) topped the 100 trillion won mark, for the first time in the South Korea...
Jan 14, 2022 (Gmt+09:00)
-
Private equity
CICC to form up to $3.3 bn funds for bio, chips in Korea and others
CICC Capital, a private equity firm of China's largest investment bank China International Capital Corporation (CICC), will create funds with a comb...
Jan 10, 2022 (Gmt+09:00)
language -
Shipping & Shipbuilding
Big 3 Korean shipbuilders win largest orders in 8 yrs
South Korea's three major shipbuilders in 2021 have received their largest amount of orders in eight years, surpassing their targets by 45%, accordi...
Dec 31, 2021 (Gmt+09:00)
-
Pharmeceuticals
Kolon resumes Invossa phase 3 clinical trials in US
Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...
Dec 28, 2021 (Gmt+09:00)
-
Pharmaceuticals
HK inno.N’s K-CAB a blockbuster drug with $843 million exports
South Korea’s HK inno.N Corp. has signed a 640 billion won ($540 million) contract to license out its technology for K-CAB, a gastroesophageal...
Dec 24, 2021 (Gmt+09:00)
-
Corporate restructuring
Hyundai Motor reshuffles overseas units to deal with changing markets
Hyundai Motor Co., South Korea’s top automaker, has reorganized its overseas units, reducing the number of business sectors to five from nine,...
Dec 19, 2021 (Gmt+09:00)
-
Entertainment
Kakao buys Asia fantasy fiction platform giant Wuxiaworld
South Korea’s Kakao Entertainment Corp. has bought the world’s top Asian fantasy web novel platform Wuxiaworld, based in the US, to expa...
Dec 16, 2021 (Gmt+09:00)
-
Biotech
Korea’s MedPacto, Merck plan phase 3 trials of colorectal cancer drug
MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...
Dec 15, 2021 (Gmt+09:00)
-
Leadership & Management
Samsung reshuffles three major CEOs, combines mobile and consumer electronics units
Samsung Electronics Co., in a surprise move, has merged its mobile and consumer electronics businesses into a single unit, and replaced chief execut...
Dec 07, 2021 (Gmt+09:00)
language -
Private equity
STIC invests $843 mn in Korean copper foil maker Iljin
South Korean private equity firm STIC Investments Inc. said on Nov. 30 it will invest 1.1 trillion won ($843.1 million) to expand Korean elecfoil ...
Nov 30, 2021 (Gmt+09:00)
-
Biotech
Celltrion looks beyond biosimilars to develop its own mRNA drugs
South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...
Nov 16, 2021 (Gmt+09:00)
-
E-commerce
MBK seeks to buy two S.Korean e-commerce platforms
MBK Partners is in talks to buy management rights of two e-commerce platforms listed on South Korea's Kosdaq market in a package deal, according to ...
Nov 09, 2021 (Gmt+09:00)
-
Automobiles
Halla Group to combine two self-driving business arms
South Korea's Halla Group, the parent company of automotive parts maker Mando Corp., will combine its two autonomous driving business units into a s...
Oct 06, 2021 (Gmt+09:00)
-
Biosimilars
Samsung Bioepis gets FDA approval for Lucentis biosimilar Byooviz
Samsung Bioepis Co., a leading South Korean biopharmaceutical company, has received approval from the US Food and Drug Administration for its Byoovi...
Sep 23, 2021 (Gmt+09:00)
-
Pharmaceuticals
High-priced drugs add to pressure for Korea's healthcare reform
A number of new rare disease treatments, approved in South Korea over the past year, are still unaffordable for the public because of their price ta...
Sep 15, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
Sovereign wealth funds
KIC replaces infrastructure, real estate heads
The Korea Investment Corporation (KIC) on Tuesday replaced its infrastructure and real estate investment heads, in a senior management reshuffle fol...
Aug 24, 2021 (Gmt+09:00)
-
Pharmaceuticals
Daewoong Pharmaceutical aims to top $4 bn in sales by 2027
South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...
Aug 04, 2021 (Gmt+09:00)
language -
Real estate
Korean housing prices soar to $5 tn in Moon admin with record growth
South Korean house prices have risen more during the President Moon Jae-in administration than any other as the current government has focused more ...
Jul 23, 2021 (Gmt+09:00)
language -
Airlines
Korean Air won't sell Asiana's budget carriers post-merger
Korean Air Lines Co. (KAL) will not put Asiana Airlines Inc.'s two low-cost carriers (LCCs) up for sale after it completes its 1.8-trillion-won ($1....
Jul 19, 2021 (Gmt+09:00)
-
E-commerce
Korea's first-generation retail platform Interpark up for sale
South Korea-based Interpark Corp., one of the country’s first-generation online retail platforms, is up for sale. According to the invest...
Jul 12, 2021 (Gmt+09:00)
language -
Biotech
LegoChem’s biotech platform drives 28% share price spike over last month
The rise of the platform economy is a global phenomenon. The spread of the coronavirus pandemic has accelerated the use of contactless technology an...
Jul 07, 2021 (Gmt+09:00)
language -
Private equity
STIC to cash in on Aug IPOs following HYBE block sale
South Korea's private equity firm STIC Investments Inc. is tipped to be one of the main beneficiaries of upcoming initial public offerings in the co...
Jul 07, 2021 (Gmt+09:00)
-
Pharmaceuticals
SK Biopharm aims to make it to global top 10 healthcare firms by 2030
South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...
Jul 02, 2021 (Gmt+09:00)
-
COVID-19
Eyegene to kick off Korea’s first mRNA clinical trial
Eyegene Inc. will be South Korea’s first vaccine maker to conduct clinical tests of messenger ribonucleic acid (mRNA) COVID-19 vaccines. Ealie...
Jul 01, 2021 (Gmt+09:00)
-
Korean chipmakers
Samsung’s new 5G multi-chip combines DRAM, NAND into one package
Samsung Electronics Co. has unveiled a new multi-chip that integrates high-performance DRAM and NAND flash memory chips into a single compact packag...
Jun 15, 2021 (Gmt+09:00)
-
Korean startups
Naver-invested startups' combined valuation increases sixfold; tops $1 bn
The combined valuation of some 70 tech startups that received funding from the platform giant Naver Corp. has reached around 1.3 trillion won ...
Jun 09, 2021 (Gmt+09:00)
-
Medicine
Celltrion, Mirae to take largest stake in UK biotech firm
South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...
Jun 07, 2021 (Gmt+09:00)
language -
COVID-19 vaccines
Samsung Bio plans to manufacture mRNA drug substance from 2022
Samsung Biologics will be entering the drug substance segment of the COVID-19 vaccine contract manufacturing business. According to industry sources...
May 31, 2021 (Gmt+09:00)
language